Advancing Cancer Treatment

Analysis

Advancing Cancer Treatment is a registered charity in United States, based in Moultonboro, NH. It received its IRS tax-exemption ruling in February 2019, 7 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Advancing Cancer Treatment reported income of $2.1m and spending of $1.3m, leaving 39% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $604k to $2.1m (+242%), an average of +36% a year. The sharpest change came in the year to December 2020, when income rose by 165%. Over the whole period it spent 78% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Advancing Cancer Treatment sits at the 72nd percentile: it is larger than about 72% of them. Against every charity in United States with reported income it ranks in the 86th percentile, and in the 88th percentile within NH. Charities of a similar size with the same main cause include Soar Case Management Services Inc ($2.1m), May-We-Help ($2.1m) and Mobilize Recovery ($2.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 97% of the total. At year end it held assets of $1.5m against liabilities of $30k, net assets of $1.5m.